Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIAT
Ratios

Bluejay Diagnostics (BJDX) EBIAT (2020 - 2026)

Bluejay Diagnostics' EBIAT history spans 2 years, with the latest figure at -$2.3 million for Q4 2023.

  • On a quarterly basis, EBIAT rose 3.5% to -$2.3 million in Q4 2023 year-over-year; TTM through Dec 2023 was -$10.0 million, a 7.07% decrease, with the full-year FY2025 number at -$6.8 million, up 11.26% from a year prior.
  • EBIAT hit -$2.3 million in Q4 2023 for Bluejay Diagnostics, roughly flat from -$2.3 million in the prior quarter.
  • Over the last five years, EBIAT for BJDX hit a ceiling of -$1.9 million in Q2 2022 and a floor of -$3.0 million in Q3 2022.